168 related articles for article (PubMed ID: 16144836)
1. Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation.
Marjanovic JA; Li Z; Stojanovic A; Du X
J Biol Chem; 2005 Nov; 280(45):37430-8. PubMed ID: 16144836
[TBL] [Abstract][Full Text] [Related]
2. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.
Zhang G; Xiang B; Dong A; Skoda RC; Daugherty A; Smyth SS; Du X; Li Z
Blood; 2011 Sep; 118(13):3670-9. PubMed ID: 21803853
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
Dangel O; Mergia E; Karlisch K; Groneberg D; Koesling D; Friebe A
J Thromb Haemost; 2010 Jun; 8(6):1343-52. PubMed ID: 20149081
[TBL] [Abstract][Full Text] [Related]
6. Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
Schäfer A; Flierl U; Kobsar A; Eigenthaler M; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2813-8. PubMed ID: 17023677
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1.
Gobeil F; Zhu T; Brault S; Geha A; Vazquez-Tello A; Fortier A; Barbaz D; Checchin D; Hou X; Nader M; Bkaily G; Gratton JP; Heveker N; Ribeiro-da-Silva A; Peri K; Bard H; Chorvatova A; D'Orléans-Juste P; Goetzl EJ; Chemtob S
J Biol Chem; 2006 Jun; 281(23):16058-67. PubMed ID: 16574649
[TBL] [Abstract][Full Text] [Related]
8. Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregation.
Kempfert J; Behrends S
Platelets; 2003; 14(7-8):429-35. PubMed ID: 14713512
[TBL] [Abstract][Full Text] [Related]
9. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity.
Gambaryan S; Kobsar A; Hartmann S; Birschmann I; Kuhlencordt PJ; Müller-Esterl W; Lohmann SM; Walter U
J Thromb Haemost; 2008 Aug; 6(8):1376-84. PubMed ID: 18485089
[TBL] [Abstract][Full Text] [Related]
10. [Role of nitric oxide/cGMP system in platelet function].
Inoue N
Nihon Rinsho; 2004 Sep; 62 Suppl 9():500-4. PubMed ID: 15506436
[No Abstract] [Full Text] [Related]
11. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
12. Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo.
Apostoli GL; Solomon A; Smallwood MJ; Winyard PG; Emerson M
J Thromb Haemost; 2014 Nov; 12(11):1880-9. PubMed ID: 25163536
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and the vascular endothelium.
Moncada S; Higgs EA
Handb Exp Pharmacol; 2006; (176 Pt 1):213-54. PubMed ID: 16999221
[TBL] [Abstract][Full Text] [Related]
14. Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/β-catenin inhibition.
De Pauw A; Massion P; Sekkali B; Andre E; Dubroca C; Kmecova J; Bouzin C; Friart A; Sibille C; Gilon P; De Mulder D; Esfahani H; Strapart A; Martherus R; Payen V; Sonveaux P; Brouckaert P; Janssens S; Balligand JL
Cardiovasc Res; 2016 Oct; 112(1):478-90. PubMed ID: 27520736
[TBL] [Abstract][Full Text] [Related]
15. Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
Kumar A; Sushama A; Manral S; Sinha R; Joshi R; Singh U; Rohil V; Prasad AK; Parmar VS; Raj HG
Nitric Oxide; 2012 Jan; 26(1):9-19. PubMed ID: 22100620
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
18. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation.
Ozüyaman B; Gödecke A; Küsters S; Kirchhoff E; Scharf RE; Schrader J
Thromb Haemost; 2005 Jun; 93(6):1161-7. PubMed ID: 15968403
[TBL] [Abstract][Full Text] [Related]
19. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
Kostic TS; Andric SA; Stojilkovic SS
Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
[TBL] [Abstract][Full Text] [Related]
20. Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates.
Goubareva I; Gkaliagkousi E; Shah A; Queen L; Ritter J; Ferro A
Cardiovasc Res; 2007 Sep; 75(4):793-802. PubMed ID: 17572401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
